GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (FRA:ILA) » Definitions » Other Long Term Assets

Imugene (FRA:ILA) Other Long Term Assets : €0.57 Mil (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Imugene Other Long Term Assets?

Imugene's other long-term assets for the quarter that ended in Dec. 2023 was €0.57 Mil.

Imugene's quarterly other long-term assets declined from Dec. 2022 (€0.01 Mil) to Jun. 2023 (€0.01 Mil) but then increased from Jun. 2023 (€0.01 Mil) to Dec. 2023 (€0.57 Mil).

Imugene's annual other long-term assets declined from Jun. 2022 (€0.02 Mil) to Jun. 2023 (€0.01 Mil) but then increased from Jun. 2023 (€0.01 Mil) to Jun. 2024 (€0.08 Mil).

Imugene Other Long Term Assets Historical Data

The historical data trend for Imugene's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imugene Other Long Term Assets Chart

Imugene Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.01 0.08

Imugene Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.57 0.08

Imugene Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Imugene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (FRA:ILA) » Definitions » Other Long Term Assets
Comparable Companies
ASX:RAC ASX:ALA ASX:DXB ASX:LTP ASX:OCC ASX:IMM ASX:EZZ ASX:PAR ASX:RCE ASX:NUZ VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
IUGNF:USA IMU:Australia
Address
4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Website
https://www.imugene.com
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.

Imugene Headlines

No Headlines